GLP1R and myocardial infarction: In addition, GLP-1 RA treatments have been shown to improve blood–brain barrier integrity, attenuate systemic inflammation, and enhance cardiac function, indicating their potential to limit ischemic damage and adverse post-myocardial infarction (MI) remodeling.